IMARX THERAPEUTICS INC (IMRX.OB) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 6 transactions totaling $758, demonstrating a bearish sentiment with -$758 in net insider flow. The most recent transaction on May 4, 2010 involved a sale of 37,905 shares valued at $758.
No significant insider buying has been recorded for IMRX.OB in the recent period.
No significant insider selling has been recorded for IMRX.OB in the recent period.
Based on recent SEC filings, insider sentiment for IMRX.OB is bearish with an Insider Alignment Score of 0/100 and a net flow of -$758. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IMARX THERAPEUTICS INC (IMRX.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading IMRX.OB stock, having executed 6 transactions in the past 90 days. The most active insider is Thomas W. Pew Jr (Executive), who has made 2 transactions totaling $758.
Get notified when executives and directors at IMRX.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 4, 2010 | W. Pew Thomas Jr | Executive | Sale | 37,905 | $0.02 | $758 | |
| Aug 21, 2009 | L. Love Richard | Executive | Award | 300,000 | $N/A | $0 | |
| Aug 21, 2009 | E. Otto Richard | Executive | Award | 300,000 | $N/A | $0 | |
| Aug 21, 2009 | W. Pew Thomas Jr | Executive | Award | 300,000 | $N/A | $0 | |
| Aug 21, 2009 | C. Ranker Philip | Executive | Award | 300,000 | $N/A | $0 | |
| Aug 21, 2009 | M. Strickland James | Executive | Award | 300,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 1 | $758 | 100.0% |
Award(A) | 5 | $0 | 0.0% |
Insider selling pressure at IMARX THERAPEUTICS INC has increased, with 5 insiders executing 6 transactions across all time. Total sales of $758 significantly outpace purchases of $0, resulting in a net outflow of $758. This selling activity appears largely discretionary, which may warrant closer attention from investors.